Clinical observation of modified Huangqi Guizhi Wuwu Decoction in the prevention and treatment of peripheral neurotoxicity induced by oxaliplatin
|更新时间:2022-08-31
|
Clinical observation of modified Huangqi Guizhi Wuwu Decoction in the prevention and treatment of peripheral neurotoxicity induced by oxaliplatin
Shanghai Journal of Traditional Chinese MedicineVol. 51, Issue 1, Pages: 53-54(2017)
作者机构:
1. 上海市浦东医院中医肿瘤科,上海,201399
作者简介:
基金信息:
DOI:
CLC:
扫 描 看 全 文
XU Cheng-xing, HU Xin-ming, XU Sen-hua. Clinical observation of modified Huangqi Guizhi Wuwu Decoction in the prevention and treatment of peripheral neurotoxicity induced by oxaliplatin. [J]. Shanghai Journal of Traditional Chinese Medicine 51(1):53-54(2017)
DOI:
XU Cheng-xing, HU Xin-ming, XU Sen-hua. Clinical observation of modified Huangqi Guizhi Wuwu Decoction in the prevention and treatment of peripheral neurotoxicity induced by oxaliplatin. [J]. Shanghai Journal of Traditional Chinese Medicine 51(1):53-54(2017)DOI:
Clinical observation of modified Huangqi Guizhi Wuwu Decoction in the prevention and treatment of peripheral neurotoxicity induced by oxaliplatin
Objective:To observe the effect of modified Huangqi Guizhi Wuwu Decoction in the prevention and treatment of peripheral neurotoxicity induced by oxaliplatin. Methods68 cases of colorectal cancer and gastric cancer who received chemotherapy of improved FOLFOX plan were randomly divided into the control group and the treatment group,34 cases in each group. The control group was treated with chemotherapy plus mecobalamin tablets and the treatment group was treated with chemotherapy plus modified Huangqi Guizhi Wuwu Decoction. After 4 cycles of chemotherapy,the occurrence of peripheral neurotoxicity and the changes of T lymphocyte subsets(CD3,+,、CD4,+,、CD4,+,/CD8,+,)were evaluated. Results:① In the treatment group,there were 6 cases of peripheral neurotoxicity in class I,3 cases in classⅡ,one case in class Ⅲ and no cases in class Ⅳ,the total incidence rate was 29.4%. In the control group,there were 11 cases of peripheral neurotoxicity in class I,5 cases in classⅡ,2 cases in class Ⅲ and no cases in class Ⅳ,the total incidence rate was 52.9%. Comparison of the total incidence rate between groups,the rate of the treatment group was obviously lower than that of the control group(P,<,0.05). ②Comparison of treatment before and after within group,there was no significant change in lymphocyte subsets in the treatment group,the levels of CD3,+,CD4,+,CD4,+,/CD8,+, were significantly decreased in the control group with statistical differences(P,<,0.05);after treatment,there were statistically significant differences on the levels of CD3,+,CD4,+,CD4,+,/CD8,+, between the two groups(P,<,0.05). Conclusion:Modified Huangqi Guizhi Wuwu Decoction can effectively reduce the peripheral neurotoxicity induced by oxaliplatin,and improve the cellular immune function of patients.
关键词
周围神经毒性黄芪桂枝五物汤奥沙利铂减毒增效
Keywords
peripheral neurotoxicityHuangqi Guizhi Wuwu Decoctionoxaliplatinreducing toxicity and increasing effects
Clinical study on the external application of Longteng Tongluo Decoction in the treatment of oxaliplatin⁃induced peripheral neuropathy
Selection on clinical diagnostic indications of wind syndrome of Taiyin based on complex network
Zhao Yuanhong’s differentiation and treatment on lower extremity venous thrombosis due to lung cancer with Huangqi Guizhi Wuwu Decoction:A case report
Effects of Changweiqing Decoction on DNA double-strand damage and homologous recombination repair factor ATM and γH2AX in nude mice with human colon cancer subcutaneous xenograft
Research on Changwei Qing medicated serum increasing chemosensitivity towards human colon cancer resistant cells HCT116/L-OHP
Related Author
No data
Related Institution
Department of Oncology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Department of Oncology, Tenth People’s Hospital of Tongji University
School of Basic Medicine,Zhejiang Chinese Medical University
Tianjin University of Traditional Chinese Medicine
Department of Oncology, First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine